Funder: National Institutes of Health
Due Dates: February 13, 2025 | March 1, 2025 (AIDS) | June 12, 2025 | July 1, 2025 (AIDS)
Funding Amounts: Up to $275,000 direct costs over 2 years (no more than $200,000 in any single year); project period max 2 years.
Summary: Supports high-risk, early-stage exploratory and developmental research in cancer diagnosis, treatment, prevention, and related clinical/preclinical studies.
Key Information: Applications focused on basic cancer biology, late-stage clinical trials, or epidemiology are not eligible; clinical trial optional.